Primary Site >> Esophagus Cancer
Gene >> CDH1
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. PMID: 11555590 |
Ref: Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. PMID: 16899597 |
Ref: Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. PMID: 20563251 |
Ref: Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. PMID: 20922573 Ref: Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. PMID: 21373750 |
Ref: Concerted loss of TGFbeta-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma. PMID: 25233932 |
Ref: FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1. PMID: 26349968 |
Ref: 5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1. PMID: 27513557 Ref: Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer. PMID: 27600761 |
Ref: Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition. PMID: 28286209 |